Lulivin Cream contains Luliconazole 1% w/w, a topical antifungal agent indicated for the treatment of superficial dermatophytic infections, including tinea corporis, tinea cruris, and tinea pedis. Luliconazole belongs to the imidazole class of antifungals and exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation ensures effective local delivery and penetration into the stratum corneum, providing rapid symptomatic relief from itching, scaling, and inflammation associated with fungal infections. Lulivin Cream is typically applied once daily to the affected area and surrounding skin for a duration of 2 to 4 weeks, depending on the severity and site of infection. It is generally well tolerated, with minimal adverse effects such as mild local irritation or burning sensation reported in some patients. Lulivin Cream should be used with caution in patients with known hypersensitivity to luliconazole or any cream excipients. It is contraindicated in mucosal infections and should not be applied to broken or eczematous skin. Proper hygiene and adherence to treatment duration are essential to prevent recurrence. Consultation with a healthcare professional is recommended before use.